Abstract
Parkinson’s disease (PD) is a common neurodegenerative disease and the mechanism underlying PD pathogenesis is incompletely understood. Increasing evidence indicates that microRNA (miRNA) plays critical regulatory role in the pathogenesis of PD. This study aimed to determine the miRNA-mRNA regulatory network for PD. The differentially expressed miRNAs (DEmis) and genes (DEGs) between PD patients and healthy donors were screened from miRNA dataset GSE16658 and mRNA dataset GSE100054 downloaded from the Gene Expression Omnibus (GEO) database. Target genes of the DEmis were selected when predicted by 3 or 4 online databases and overlapped with DEGs from GSE100054. Next, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was conducted by Database for Annotation, Visualization and Integrated Discovery (DAVID) and Metascape analytic tool. The correlation between the screened genes and PD was evaluated by the online tool Comparative Toxicogenomics Database (CTD). The protein-protein interactions (PPI) network was built by STRING platform. Finally, we testify the expression of members of the miRNA-mRNA regulatory network in the blood samples collected from PD patients and healthy donors by using qRT-PCR. 1505 upregulated and 1302 downregulated DEGs, 77 upregulated DEmis and 112 downregulated DEmis were preliminarily screened from GEO database. Through further functional enrichment analysis, 10 PD-related hub genes were selected, including RAC1, IRS2, LEPR, PPARGC1A, CAMKK2, RAB10, RAB13, RAB27B, RAB11A and JAK2, which were mainly involved in Rab protein signaling transduction, AMPK signaling pathway and signaling by Leptin. The miRNA-mRNA regulatory network was constructed with 10 hub genes and their interacting miRNAs overlapped with DEmis, including miR-30e-5p, miR-142-3p, miR-101-3p, miR-32-3p, miR-508-5p, miR-642a-5p, miR-19a-3p and miR-21-5p. Analysis on clinical samples verified significant upregulation of LEPR and downregulation of miR-101-3p in PD patients compared with healthy donors. In the study, the potential miRNA-mRNA regulatory network was constructed in PD, which may provide novel insight into pathogenesis and treatment of PD.